Ultra-High Dose Oral ω3 Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA), or Oxidation-Resistant Deuterated DHA Block Tumorigenesis in a MYCN-Driven Neuroblastoma Model
Open Access
Abstract
Background/Objectives: Neuroblastoma is a genetically diverse, highly metastatic pediatric cancer accounting for 15% of childhood cancer deaths despite only having ~8% of childhood cancer incidence. The current standard of care for high-risk diseases is highly genotoxic. This, combined with less than 50% survival in high-risk diseases and an abysmal 5% survival in relapsed cases, makes discovering novel, effective, and less toxic treatments essential. Methods: A prophylactic syngeneic mouse model was used to test high-dose lipid-mediator highly unsaturated fatty acids on tumorigenesis. Wildtype mice were gavaged with 12.3–14.6 g/d (adult human equivalent) omega-3 EPA, DHA, or oxidation-resistant bis allylic deuterated DHA (D-DHA) and 4.6–6.0 g/d arachidonic acid (ARA). At seven days, MYCN-expressing murine neuro-2a cells syngeneic to the gavaged mice were injected subcutaneously. Oral gavage continued for 10–20 d post-injection when tumors and tissues were harvested. Results: Fifty percent of control (not gavaged) animals form tumors (4/8) at about 10 d. High-dose DHA, D-DHA, and EPA block tumor formation completely in n = 8 or 10 animals. In contrast, ω6 arachidonic acid (4.6–6.0 g/d) enhances tumor formation (6/10 tumors) and reduces latency (5.5 to 10 days) compared to the control. The co-delivery of ARA and EPA results in a reduced tumor burden analogous to the control group, suggesting that EPA directly opposes the mechanism of ARA-mediated tumor formation. DHA acts through a non-oxidative mechanism. Conclusions: Sustained high-dose ω3 (weeks/months) is safe and well-tolerated in humans. These results suggest that ω3 DHA and EPA delivery at ultra-high doses may represent a viable low-toxicity therapy for neuroblastoma.Keywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RR180034)
This publication has 40 references indexed in Scilit:
- Pharmacokinetics and metabolism in mouse retina of bis-allylic deuterated docosahexaenoic acid (D-DHA), a new dry AMD drug candidateExperimental Eye Research, 2022
- Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functionsProgress in Lipid Research, 2022
- Treatment of Severe Hypertriglyceridemia During Pregnancy With High Doses of Omega-3 Fatty Acid and PlasmapheresisAACE Clinical Case Reports, 2021
- Polyunsaturated Fatty Acid Deuteration against NeurodegenerationTrends in Pharmacological Sciences, 2020
- Update on neuroblastomaJournal of Pediatric Surgery, 2019
- Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acidsProgress in Lipid Research, 2013
- Distinct roles of different forms of vitamin E in DHA‐induced apoptosis in triple‐negative breast cancer cellsMolecular Nutrition & Food Research, 2012
- GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell lineJournal of Neuro-Oncology, 2010
- One-Step Lipid Extraction and Fatty Acid Methyl Esters Preparation from Fresh Plant TissuesAnalytical Biochemistry, 1993
- Fatty acid composition in native and cultured human endothelial cellsIn Vitro Cellular & Developmental Biology - Plant, 1984